| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |